It is unlikely that the same patents are being sold to two different companies. So, REVO must choose one company over the other. And it seems that they have chosen the company (rumored to be Google) which appeared on the scene after September.
That makes a Schedule 14A proxy and shareholder vote on the September 'deal' irrelevant. Doesn't it?